Home
  • Home
  • Resources
  • Diseases
  • Compendium
  • Training
  • Evaluation
    • The Tool
    • The Tutorial
  • SYSVAC
    • About
    • Registry
    • E-learning courses
  • News
  • Webinars
  • Network
    • Steering Committee
    • Vision and Mission
    • Map
    • Meetings
    • Partners
    • Join us
  • Home
  • Diseases
  • Japanese encephalitis
Diseases

Japanese encephalitis

SAGE recommendations and background documents
Find out more
2015 ∙ SAGE
What is the risk of serious adverse events following vaccination with live recombinant JE vaccine?
Download:
  • EN
AEFI GRADE table Japanese encephalitis
2015 ∙ SAGE
What is the risk of serious adverse events following vaccination with live attenuated JE vaccine?
Download:
  • EN
AEFI GRADE table Japanese encephalitis
2015 ∙ SAGE
What is the risk of serious adverse events following vaccination with inactivated Vero cell-derived JE vaccine?
Download:
  • EN
GRADE table Japanese encephalitis
2015 ∙ SAGE
Is there a need for a booster dose following immunization with a single dose of live recombinant JE vaccine in vaccinees living in JE-endemic areas?
Download:
  • EN
GRADE table Japanese encephalitis
2015 ∙ SAGE
Is there a need for a booster dose following immunization with one dose of live attenuated JE vaccine in individuals living in JE-endemic areas?
Download:
  • EN
GRADE table Japanese encephalitis
2015 ∙ SAGE
Is there a need for a booster dose following immunization with the primary series of inactivated Vero cell-derived JE vaccine in individuals living in JE-endemic areas?
Download:
  • EN
GRADE table Japanese encephalitis
2015 ∙ SAGE
What is the effectiveness of live recombinant JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
Download:
  • EN
GRADE table Japanese encephalitis
2015 ∙ SAGE
What is the effectiveness of live attenuated JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
Download:
  • EN
GRADE table Japanese encephalitis
2015 ∙ SAGE
What is the effectiveness of inactivated Vero cell-derived JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
Download:
  • EN
GRADE table Japanese encephalitis
  • Home
  • Resources
  • Diseases
  • Compendium
  • Training
  • Evaluation
  • SYSVAC
  • News
  • Webinars
  • Network
  • Sign in / Register
National Immunization Technical Advisory Groups
  • Home
  • Resources
  • Diseases
  • Compendium
  • Training
  • Evaluation
  • SYSVAC
  • News
  • Webinars
  • Network
© 2025
  • Legal Notice
Subscription to the monthly updates

At the end of each month, we share the latest NITAG recommendations from across all regions, highlight key articles related to NITAG activities, and provide important announcements. Stay informed - don’t miss out!

Loading...